Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
SAR441566 for Ulcerative Colitis
Recruiting0 awardsPhase 2
Greenville, North Carolina
This trial is testing a new drug called SAR441566 in adults with moderate-to-severe ulcerative colitis. The study will last about 59 weeks and will involve taking the drug for either
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service